| # | Title | Journal | Year | Citations |
|---|
| 1 | Ras target proteins in eukaryotic cells | FASEB Journal | 1995 | 304 |
| 2 | The effector interactions of p21ras | Trends in Biochemical Sciences | 1993 | 203 |
| 3 | Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy | Cancer | 2013 | 173 |
| 4 | v-Src-Induced Modulation of the Calpain-Calpastatin Proteolytic System Regulates Transformation | Molecular and Cellular Biology | 2002 | 107 |
| 5 | Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth | Leukemia | 2017 | 101 |
| 6 | Drug Insight: VEGF as a therapeutic target for breast cancer | Nature Clinical Practice Oncology | 2007 | 93 |
| 7 | Results of Treatment After Relapse From High-Dose Chemotherapy in Germ Cell Tumors | Journal of Clinical Oncology | 2000 | 85 |
| 8 | A phase II study of methylphenidate for the treatment of fatigue | Supportive Care in Cancer | 2006 | 77 |
| 9 | Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors | | 2000 | 64 |
| 10 | The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells | Leukemia | 2016 | 49 |
| 11 | Clinical Management of Thymoma Patients | Hematology/Oncology Clinics of North America | 2008 | 48 |
| 12 | Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope? | Frontiers in Cell and Developmental Biology | 2020 | 48 |
| 13 | The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients | Journal of Cancer Research and Clinical Oncology | 2008 | 33 |
| 14 | Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma | BMC Medical Genomics | 2019 | 33 |
| 15 | The Story of Angiogenesis Inhibitors in Non–small-cell Lung Cancer: The Past, Present, and Future | Clinical Lung Cancer | 2020 | 26 |
| 16 | Prognostic Biomarkers for Acute Graft-versus-Host Disease Risk after Cyclophosphamide–Fludarabine Nonmyeloablative Allotransplantation | Biology of Blood and Marrow Transplantation | 2014 | 25 |
| 17 | Calpain Regulates Enterocyte Brush Border Actin Assembly and Pathogenic Escherichia coli-mediated Effacement | Journal of Biological Chemistry | 2003 | 24 |
| 18 | Pathological complete response with anti-PD-1 therapy in a patient with microsatellite instable high, BRAF mutant metastatic colon cancer: a case report and review of literature | Discovery Medicine | 2016 | 21 |
| 19 | Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial | Bone Marrow Transplantation | 2012 | 20 |
| 20 | Novel Combination Treatments Targeting Chronic Myeloid Leukemia Stem Cells | Clinical Lymphoma, Myeloma and Leukemia | 2012 | 19 |
| 21 | Serum Protein Profiling to Identify High-Risk Neuroblastoma: Preclinical Relevance of Blood-Based Biomarkers | Journal of Surgical Research | 2007 | 18 |
| 22 | A multi-center phase II trial evaluating the efficacy of palbociclib in combination with carboplatin for the treatment of unresectable recurrent or metastatic head and neck squamous cell carcinoma | Investigational New Drugs | 2020 | 17 |
| 23 | Cyclo-oxygenase-2 expression in primary cancers of the lung and bladder compared to normal adjacent tissue | Cancer Detection and Prevention | 2002 | 16 |
| 24 | The ethics of CYP2D6 testing for patients considering tamoxifen | Breast Cancer Research | 2007 | 15 |
| 25 | Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells | Bone Marrow Transplantation | 1997 | 14 |
| 26 | Antiangiogenic Agents in Breast Cancer | Cancer Investigation | 2007 | 12 |
| 27 | Breast Cancer in the Information Age: A Review of Recent Developments | Breast Disease | 2004 | 11 |
| 28 | Paclitaxel Plus Gallium Nitrate and Filgrastim in Patients With Refractory Malignancies | American Journal of Clinical Oncology: Cancer Clinical Trials | 1998 | 11 |
| 29 | Treatment of Acute Myeloid Leukemia in Elderly Patients—A Therapeutic Dilemma | Journal of the American Medical Directors Association | 2016 | 10 |
| 30 | Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype–Guided Dosing | Clinical Cancer Research | 2020 | 10 |
| 31 | Prospective randomized trial of 5-fluorouracil versus 5-fluorouracil plus levamisole in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial | Clinical Cancer Research | 1998 | 10 |
| 32 | In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma | Blood Cancer Journal | 2020 | 9 |
| 33 | Gender differences in question-asking at the 2019 American Society of Hematology Annual Meeting | Blood Advances | 2020 | 7 |
| 34 | Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity | Npj Genomic Medicine | 2021 | 7 |
| 35 | Proteomic Analysis of Neuroblastoma Microenvironment: Effect of the Host–Tumor Interaction on Disease Progression | Journal of Surgical Research | 2009 | 6 |
| 36 | Iron chelation therapy in myelodysplastic syndromes | American Journal of Health-System Pharmacy | 2010 | 3 |
| 37 | Evaluating the Role of Serotonin on Neuropsychological Function After Breast Cancer Using Acute Tryptophan Depletion | Biological Research for Nursing | 2012 | 3 |
| 38 | The complexity of reproductive decisions for patients with advanced cancer: ethical and communicative dimensions | The Journal of Supportive Oncology | 2010 | 1 |
| 39 | Introduction | American Journal of Health-System Pharmacy | 2010 | 0 |
| 40 | New advances in local therapy for colorectal cancer metastases to the liver | Colorectal Cancer | 2014 | 0 |
| 41 | Considerations When Treating Patients with Good-risk Germ Cell Tumors | European Urology Focus | 2020 | 0 |
| 42 | Unlike Inactivating PTEN Mutations, Pharmacological Inhibition of PTEN Does Not Increase the Sensitivity of Multiple Myeloma Cells to Inhibition of the PI3K/Akt/mTOR Pathway. | Blood | 2007 | 0 |
| 43 | Mutations in CRBN and Other Cereblon Pathway Genes Are Only Associated with Acquired Resistance to Immunomodulatory Drugs in a Subset of Patients and Cell Line Models | Blood | 2020 | 0 |
| 44 | Physical, psychological, and spiritual transformation at life's end: toward a theory of convergence | The Journal of Supportive Oncology | 2005 | 0 |
